1 result for "Azitra Inc"
Add this URL to any RSS reader. Updated daily.
Netherton Syndrome LEKTI Microbe Patent - Azitra Inc
The USPTO granted US Patent 12606610B2 to Azitra Inc covering engineered microbes expressing recombinant LEKTI domains for the treatment of Netherton Syndrome. The patent contains 15 claims spanning compositions, methods, and kits. Inventors are Travis Michael Whitfill and Azim Momin Munivar.
Routine
Notice
Intellectual Property
Get alerts for "Azitra Inc"
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Browse Categories
Agriculture & Food Safety
73
AI Regulation
3
Banking & Finance
412
Consumer Protection
89
Courts & Legal
411
Data Privacy & Cybersecurity
90
Defense & National Security
53
Education
55
Energy
100
Environment
152
Gaming
2
Government & Legislation
430
Healthcare
15
Healthcare & Life Sciences
375
Immigration
10
Insurance
76
Labor & Employment
134
Pharma & Drug Safety
21
Professional Licensing
8
Real Estate & Housing
78
Securities & Markets
154
Tax
78
Telecom & Technology
47
Trade & Sanctions
141
Transportation
91
Get alerts for "Azitra Inc"
We'll email you when new changes match "Azitra Inc".
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.
You're subscribed!